Search

Your search keyword '"Purkayastha D"' showing total 211 results

Search Constraints

Start Over You searched for: Author "Purkayastha D" Remove constraint Author: "Purkayastha D"
211 results on '"Purkayastha D"'

Search Results

1. Cost-effectiveness of roflumilast as an add-on to triple inhaled therapy versus triple inhaled therapy in patients with severe and very severe COPD associated with chronic bronchitis in the UK

8. Policy brief. Finding the gap: addressing the international migration data gaps

21. Identification of symbol digit modality test score extremes in Huntington's disease

24. Firm-specific advantages, multinational joint ventures, and host country tariff policy

26. S853 SUCCESSOR: A MULTICENTER RETROSPECTIVE NONINTERVENTIONAL FOLLOW-UP STUDY IN PATIENTS WITH SICKLE CELL PAIN CRISES WHO PREVIOUSLY PARTICIPATED IN THE SUSTAIN TRIAL IN THE UNITED STATES

27. Triplet therapy (continuous ribociclib, everolimus, exemestane) in HR+/HER2− advanced breast cancer postprogression on a CDK4/6 inhibitor (TRINITI-1): Efficacy, safety, and biomarker results.

30. Radius: Midostaurin (mido) Plus Standard of Care (SOC) after Allogeneic Stem Cell Transplant (alloSCT) in Patients (pts) with FLT3-Internal Tandem Duplication (ITD)–Mutated Acute Myeloid Leukemia (AML)

34. Maintenance of health-related quality of life in elderly patients treated with ribociclib + letrozole in MONALEESA-2.

35. Abstract P5-21-27: Efficacy and safety of ribociclib plus letrozole in US patients enrolled in the MONALEESA-2 study

36. Abstract PD5-11: Not presented

37. Abstract P4-10-07: Patient-centered initiatives for improving trial participation of diverse patient populations in the open-label phase 3b compLEEment-1 study of ribociclib plus letrozole in the treatment of HR+/HER2- advanced breast cancer

38. MDR1 expression predicts outcome of Ph+ chronic phase CML patients on second-line nilotinib therapy after imatinib failure

Catalog

Books, media, physical & digital resources